Medicrea (EPA:ALMED) said today it closed a $30 million offering of senior secured notes. In the offering, the company floated $30 million in senior secured and guaranteed notes to investment firm Perceptive Advisors, with notes slated to be issued today and mature on the same day in 2022, the France-based company said. “We are excited about […]
Medicrea (EPA:ALMED) said today it is listing on the OTC exchange and will begin trading on the OTCQX Best Market under the tickers “MRNTY” and “MRNTF” starting tomorrow. The France-based company said it will list under two separate tickers representing its American Depository Receipts under “MRNTY” and its ordinary shares under “MRNTF.” Each ADR represents one […]
Medicrea (EPA:ALMED) said today it inked a joint-venture deal with Belgian distributor Motion Medical looking to accelerate adoption of its products in Belgium. France-based Medicrea will hold a 51% majority stake in the newly formed Medicrea Belgium with plans to transition the JV into a fully-owned Medicrea subsidiary over the coming years. The newly founded subsidiary […]
Medicrea (EPA:ALMED) said today it won FDA clearance for its IB3D portfolio of 3D-printed titanium interbody devices featuring its AdapTEK technology. The company’s AdapTEK technology is intended to allow surgeons to create interbody devices customized to individual specifications through in-house additive manufacturing techniques. Customization features include different ranges of footprints, lordotic angles, heights, lateral windows and […]
Medicrea (EPA:ALMED) is seeking a temporary restraining order against K2M Spine and Kinetic Surgical, as well as former sales representatives Chad Jackson, Thom Thomas, Lauren Brown and William Haigh, according to court documents filed last week. The company wrote that K2M is trying to play “catch-up” with Medicrea, alleging that it has poached 27% of the […]
Medical sterilization company Sterilis said yesterday it tapped former Nanosphere (NSDQ:NSPH) chief exec Michael McGarrity as its new CEO. McGarrity held the CEO position at Nanosphere from February 2013 to last June when he oversaw the company’s $76.9 million acquisition by Luminex (NSDQ:LMNX). Prior to his time as head of Nanosphere, McGarrity held positions in sales, marketing […]
Medicrea (EPA:ALMED) said today it filed a 510(k) submission to the FDA seeking approval of its 3D-printed titanium interbody devices. The New York City and Lyon, France-based company’s 3D-printed interbody device services include compatible UNiD Lab personalized surgical planning and analytical services, the company said. “As the 1st company in spine to develop the highly technical capabilities […]
Medicrea (EPA:ALMED) said it raised a funding round worth about $22.3 million for its UniD patient-specific spinal rod technology and tapped GMEd co-founder Richard Kienzle as its new chief commercial & business development officer. New York City and Lyon, France-based Medicrea said the €20 million round consisted of about $16.8 million (€15 million) in 4-year, 6.75% […]
Medicrea said it won 510(k) clearance from the FDA for its UNiD device, billed as the world’s 1st patient-specific spinal osteosynthesis rod.
MASSDEVICE ON CALL — A team of French doctors were the 1st to implant a patient with a customized spinal cage, thanks to 3D printed technology and development by device maker Medicrea.
Medicrea’s UNiD system 1st creates 3D digital images of a patient’s spinal anatomy, using them as a blueprint to produce an inter-body device aligned perfectly to the patients’ spine. The cages separate the vertebrae to restore proper alignment, with a spinal screw for added stability.